Betulinic acid derivatives with HIV maturation inhibitory activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9920090
SERIAL NO

15313139

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivaties that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II and III:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIIV HEALTHCARE UK (NO 5) LIMITED980 GREAT WEST ROAD BRENTFORD MIDDLESEX TW89GS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goswami, Animesh New Brunswick, US 13 456
Guo, Zhiwei Sammamish, US 20 235
Liu, Zheng Wallingford, US 491 1992
Meanwell, Nicholas A Wallingford, US 189 2698
Regueiro-Ren, Alicia Wallingford, US 73 432
Swidorski, Jacob Wallingford, US 32 149
Tully, Thomas P New Brunswick, US 6 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00